Nutritional Stress Induced by Tryptophan-Degrading Enzymes Results in ATF4-Dependent Reprogramming of the Amino Acid

Elina Timosenko1, Hemza Ghadbane1, Jonathan D Silk1

  • 1MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.

Cancer Research
|September 22, 2016
PubMed

Insights

Tumors use tryptophan degradation to evade immune responses. Cancer cells compensate by upregulating amino acid transporters, unlike T cells, indicating a poor prognosis for tumors expressing indoleamine 2,3-dioxygenase (IDO) and SLC1A5.

Area of Science:

  • Immunology
  • Cancer Biology
  • Molecular Biology

Background:

  • Tryptophan degradation is a known tumor immune escape mechanism.
  • The compensatory mechanisms of cancer cells facing tryptophan starvation are not fully understood.

Purpose of the Study:

  • To investigate the adaptive responses of cancer cells and T cells to tryptophan deficiency.
  • To elucidate the role of amino acid transporters in tumor immune evasion.

Main Methods:

  • Analysis of tryptophan-degrading enzymes indoleamine 2,3-dioxygenase (IDO) and tryptophan 2,3-dioxygenase (TDO).
  • Assessment of ATF4-dependent upregulation of amino acid transporters, including SLC1A5 and its isoforms.
  • Comparison of SLC1A5 regulation in tumor cells versus human T cells under varying tryptophan conditions.

Main Results:

  • IDO and TDO expression led to ATF4-dependent upregulation of SLC1A5 and its isoforms, enhancing tryptophan and glutamine uptake in cancer cells.
  • SLC1A5 upregulation was not observed in resting human T cells under low tryptophan conditions.
  • T-cell receptor engagement enhanced SLC1A5 in T cells, suggesting differential regulation.

Conclusions:

  • Tumor cells exhibit distinct adaptive mechanisms to tryptophan starvation compared to T cells.
  • The coexpression of IDO and SLC1A5 in tumors is associated with a poor prognosis.
  • Understanding these differences provides insights into cancer immune evasion strategies.

Related Concept Videos

Amino Acid Biosynthetic Pathways01:29

Amino Acid Biosynthetic Pathways

Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which...
1.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Repressible Operon: trp Operon01:21

Repressible Operon: trp Operon

The trp operon in Escherichia coli exemplifies a repressible operon. It regulates the synthesis of tryptophan through repressor-mediated transcriptional control and attenuation. This dual regulatory mechanism ensures tryptophan biosynthesis occurs only when needed, conserving cellular resources.Structure of the trp OperonThe trp operon consists of five structural genes (trpE, trpD, trpC, trpB, and trpA) that encode enzymes for tryptophan biosynthesis. These genes are transcribed as a single...
2.2K
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
4.5K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
63
Stringent Response in E. coli01:23

Stringent Response in E. coli

Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
450